CSL Limited is a leading Australian multinational biotechnology company specializing in the research, development, manufacturing, and marketing of lifesaving medicines and vaccines. The company’s port... CSL Limited is a leading Australian multinational biotechnology company specializing in the research, development, manufacturing, and marketing of lifesaving medicines and vaccines. The company’s portfolio includes plasma-derived therapies for conditions such as hemophilia and immune deficiencies, influenza vaccines, and treatments for rare and serious diseases. CSL operates globally through its core divisions—CSL Behring, CSL Seqirus, and CSL Vifor—serving patients in over 100 countries. With a history dating back to 1916, CSL has played a pivotal role in advancing public health, including during major global health events like the COVID-19 pandemic. The company is listed on the CHI-X Market Australia – Limit Venue, providing investors access to one of the largest and most innovative biotech firms in the Asia-Pacific region. CSL’s commitment to scientific innovation and global health continues to shape the biotechnology sector and drive advancements in patient care.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

CSL is not subject to EU Taxonomy reporting

Based on current regulatory requirements, CSL is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review CSL's data?

Start your 30-day free trial to request a data review for CSL.

Start Free Trial

Legal Center Contact Us